Preference study on medical insurance access criteria for rare disease medications: based on the perspective of medical insurance experts

Shao Jiachen, Li Shunping, Chen Jingdan, Yuan Jiaqi, Li Linkang

Health Development and Policy Research ›› 2026, Vol. 29 ›› Issue (4) : 639-646.

PDF(1225 KB)
Welcome to visit Health Development and Policy Research!
PDF(1225 KB)
Health Development and Policy Research ›› 2026, Vol. 29 ›› Issue (4) : 639-646. DOI: 10.12458/HDPR.202509004
Medical Insurance

Preference study on medical insurance access criteria for rare disease medications: based on the perspective of medical insurance experts

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 29(4): 639-646 https://doi.org/10.12458/HDPR.202509004

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1225 KB)

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉